Among all these, tumor-derived CCL2 stimulates the accumulation of myeloid cells and controls the differentiation of MDSCs into immunosuppressive macrophages, which in turn enhance metastases formation (e.g., CSCs establishment, proliferation and differentiation). Here, CCL2 is linked to neoplasm.